Clinical Trials - Pulmonary Hypertension

PF study — A study of a long-acting phosphodiesterase inhibitor as monotherapy or in combination with other treatments for pulmonary hypertension.
Primary investigator: Johannes Kuiper, MD


Top of Page

Actively enrolling studies:

  1. Atrial Fibrillation and Arrythmias
  2. Coronary Artery Disease
  3. Congestive Heart Failure
  4. Hypertension
  5. Hypertrophic Cardiomyopathy
  6. Kidney Disease and the Heart
  7. Peripheral Vascular Disease
  8. Pulmonary Hypertension
  9. Valve Disease

Warning

Your Session will expire in 5 minutes

Please click the "Continue Session" button below to continue using the website. To end your session please click the "End Session" button below. After 5 minutes of inactivity your session will be terminated and you will be required to log in again.